Acetylsalicylic acid Recruiting Phase 4 Trials for Coronary Artery Disease / Percutaneous Coronary Intervention (PCI) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03378934Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
NCT03417388Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD
NCT04006288Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease